Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery (PANDA X)

NCT06723366 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT06723366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06723366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery (PANDA X)
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
December 31, 2025
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, cardio-pulmonary bypass, cardiovascular surgery, cerebral protection